MULTIVARIATE ANALYSIS OF RISK FACTORS IN STAGE IV NEUROBLASTOMA PATIENTS OVER THE AGE OF ONE YEAR TREATED WITH MEGATHERAPY AND STEM CELL TRANSPLANTATION: A REPORT FROM THE EUROPEAN BONE MARROW TRANSPLANTATION SOLID TUMOR REGISTRY.